The 73-page report, “‘It’s Happening Even Without You Noticing’: Increasing Barriers to Accessing Sexual and Reproductive ...

But a weaker economy and the company's aggressive pricing strategy have negative read-throughs for XROLF's future US market ...

Ginebra San Miguel continues to show strong financial performance in 2024 despite challenges from the Philippine Sin Tax Law.

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Chanson International Holding (the "Company" or "Chanson"), a provider of bakery, seasonal, and beverage products through its chain stores in China and the United States, today announced its financial ...

This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...

US biotech MoonLake Immunotherapeutics (Nasdaq: MLTX) has entered into an agreement with Hercules Capital (NYSE: HTGC) for up to $500 million in non-dilutive capital, of which $75 million drawn down ...

JPMorgan would like to be lighter in IT positioning as it expects financial year 2026 to be a complete washout.

Follow the latest on Trump’s tariff war; Stock markets around the world tumbled on Thursday, the dollar sank and oil prices ...

Trump’s tariffs will impact all consumers but will be felt more acutely by households with the lowest disposable incomes, ...